Alison Bauer, University of Colorado Cancer Center (IMAGE)
Caption
Alison Bauer, Ph.D., and colleagues describe epiregulin as a new potential biomarker and target in lung cancer.
Credit
University of Colorado Cancer Center
Usage Restrictions
None
License
Licensed content